AI assistant
ORACLE CORP — Director's Dealing 2022
Dec 16, 2022
29742_dirs_2022-12-16_edfc15c3-d064-402e-9878-bf7617d51d7f.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ORACLE CORP (ORCL)
CIK: 0001341439
Period of Report: 2022-12-14
Reporting Person: HENLEY JEFFREY (Director, Vice Chairman)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-12-14 | Common Stock | M | 400000 | $30.11 | Acquired | 2192688 | Indirect |
| 2022-12-14 | Common Stock | S | 84232 | $81.2519 | Disposed | 2108456 | Indirect |
| 2022-12-14 | Common Stock | S | 281741 | $82.1418 | Disposed | 1826715 | Indirect |
| 2022-12-14 | Common Stock | S | 34027 | $82.6831 | Disposed | 1792688 | Indirect |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2022-12-14 | Stock Option | $30.11 | M | 400000 | Disposed | 2023-07-01 | Common Stock (400000) | Direct |
Footnotes
F1: Sale of shares pursuant to Rule 10b5-1 Plan adopted on September 28, 2022.
F2: This transaction was executed in multiple trades at prices ranging from $80.63 to $81.62. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F3: This transaction was executed in multiple trades at prices ranging from $81.63 to $82.62. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F4: This transaction was executed in multiple trades at prices ranging from $82.63 to $82.88. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.
F5: 25% of the shares subject to the option vested annually on each anniversary of the grant date.